Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLAIR: GSK1265744 LA in HIV Uninfected Men
NCT02076178Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Mar 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabotegravir in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Mar 2014; status: completed.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02076178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076178.